204 related articles for article (PubMed ID: 17585951)
1. Retinal and choroidal microangiopathies: therapeutic opportunities.
Afzal A; Shaw LC; Ljubimov AV; Boulton ME; Segal MS; Grant MB
Microvasc Res; 2007; 74(2-3):131-44. PubMed ID: 17585951
[TBL] [Abstract][Full Text] [Related]
2. Ocular neovascularization: basic mechanisms and therapeutic advances.
Dorrell M; Uusitalo-Jarvinen H; Aguilar E; Friedlander M
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S3-19. PubMed ID: 17240254
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
Kinnunen K; Ylä-Herttuala S
Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
[TBL] [Abstract][Full Text] [Related]
4. [Neovascularization in ocular tissues: mechanisms and role of proangiogenic and antiangiogenic factors].
Nowak JZ; Wiktorowska-Owczarek A
Klin Oczna; 2004; 106(1-2):90-7. PubMed ID: 15218775
[TBL] [Abstract][Full Text] [Related]
5. Ocular neovascularization: a valuable model system.
Campochiaro PA; Hackett SF
Oncogene; 2003 Sep; 22(42):6537-48. PubMed ID: 14528278
[TBL] [Abstract][Full Text] [Related]
6. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.
Tong JP; Yao YF
Clin Biochem; 2006 Mar; 39(3):267-76. PubMed ID: 16409998
[TBL] [Abstract][Full Text] [Related]
7. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy.
Zhang SX; Ma JX
Prog Retin Eye Res; 2007 Jan; 26(1):1-37. PubMed ID: 17074526
[TBL] [Abstract][Full Text] [Related]
8. Ocular angiogenesis: the role of growth factors.
Kvanta A
Acta Ophthalmol Scand; 2006 Jun; 84(3):282-8. PubMed ID: 16704684
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
10. Pericytes and ocular diseases.
Motiejūnaite R; Kazlauskas A
Exp Eye Res; 2008 Feb; 86(2):171-7. PubMed ID: 18078933
[TBL] [Abstract][Full Text] [Related]
11. Rationale for combination therapies for choroidal neovascularization.
Spaide RF
Am J Ophthalmol; 2006 Jan; 141(1):149-56. PubMed ID: 16386991
[TBL] [Abstract][Full Text] [Related]
12. VEGF is clearly an exciting point of attack in the treatment of neovascular diseases of the retina and choroid.
Coimbra JC
Ophthalmologica; 2012; 227 Suppl 1():1. PubMed ID: 22645747
[No Abstract] [Full Text] [Related]
13. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
[TBL] [Abstract][Full Text] [Related]
15. Combination angiostatic therapies: targeting multiple angiogenic pathways.
Friedlander M
Retina; 2009 Jun; 29(6 Suppl):S27-9. PubMed ID: 19553794
[TBL] [Abstract][Full Text] [Related]
16. [Mexican clinical experience in ocular anti-angiogenic therapy].
Quiroz-Mercado H; Vélez-Montoya R; Fromow-Guerra J; Guerrero-Naranjo JL; Moreno-Páramo D; Morales-Cantón V
Gac Med Mex; 2008; 144(3):245-53. PubMed ID: 18714594
[TBL] [Abstract][Full Text] [Related]
17. Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.
Lima E Silva R; Kachi S; Akiyama H; Shen J; Aslam S; Yuan Gong Y; Khu NH; Hatara MC; Boutaud A; Peterson R; Campochiaro PA
J Cell Physiol; 2006 Jul; 208(1):161-6. PubMed ID: 16557520
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice.
Nagai T; Imai H; Honda S; Negi A
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5716-21. PubMed ID: 18055824
[TBL] [Abstract][Full Text] [Related]
19. Protein transport to choroid and retina following periocular injection: theoretical and experimental study.
Mac Gabhann F; Demetriades AM; Deering T; Packer JD; Shah SM; Duh E; Campochiaro PA; Popel AS
Ann Biomed Eng; 2007 Apr; 35(4):615-30. PubMed ID: 17277991
[TBL] [Abstract][Full Text] [Related]
20. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis.
Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K
Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
